Dr. Dan Herman is breaking new ground and old saws with his provocative, newly-released book, “Outsmart the MBA Clones: The Alternative Guide to Competitive Strategy, Marketing, and Branding”. The book cracks the secret of companies that have been immensely successful for many years, are adored by their customers, and yet are not imitated by competitors. This position, coined “Unfair Advantage” by Dr. Herman, provides companies with their own private monopoly.
The book’s website: www.outsmart-mba-clones.com (extensive downloadable media kit). Review copies are available upon request.
Outsmart the MBA Clones (Paramount Market Publishing, 262 pp, Hardcover, $44.95) is available on Amazon.com.
Dr. Herman maintains that despite the apparent diversity among MBA programs, they produce executives who think and act in a similar and predictable manner. This undermines the competitiveness of their companies and provides a strategic advantage to those who recognize these biases and think differently.
“Outsmart the MBA Clones” provides a set of new concepts and a toolkit unlike anything taught in MBA schools. The ambitious promise of this book is to help managers create business strategies that will succeed and yet amazingly will not be copied by the competition, resulting in private monopolies.
Steve Yastrow, author of We: The Ideal Customer Relationship says: “Outsmart the MBA Clones is filled with powerful insights, appearing one after the other, that will have you thinking, ‘Hey, I never thought of it that way.’ Herman challenges long-held beliefs about strategy, competitive advantage, marketing, customer segmentation, differentiation, and branding, to name only a few.â€
“The only thing scarier than your competition already reading this book is how they may be applying it in the market that could have been yours,†said Ray Podder of Grow, a premier brand consulting firm based in California.
Dr. Dan Herman is CEO of Competitive Advantages (www.advantagizers.com), an author, lecturer, and globally renowned strategy consultant. He identifies growth opportunities, creates effective differentiation, advantages, and even private monopolies for his clients worldwide, including global corporations such as Coca Cola, IBM, Motorola, Europcar, and Roche Pharmaceuticals among others.
